News
Filtrar por
Content with Year .
Comunicado
VaxThera and Seguros SURA Launch Colombia's Largest Regional Program to Prevent HPV Associated Cancer
In Colombia, cervical cancer is the leading cause of cancer-related death among women between the ages of 20 and 35.
More information
Comunicado
Colombian Company VaxThera Receives Key Patent Grant for Locally Developed COVID-19 Vaccine
VaxThera received a patent for its COVID-19 vaccine from the United States Patent and Trademark Office (USPTO)
More information
Comunicado
The Ministry of Health and Social Protection of Colombia and the National Health Institute of Colombia sign an agreement with VaxThera to strengthen health sovereignty
The Special Framework Agreement for Scientific and Technological Cooperation signed by Colombia's Ministry of Health, the National Health Institute (INS), and VaxThera represents an innovation model aimed at bringing together efforts to strengthen local capabilities in health sovereignty.
More information